ArticleCancer chemotherapy and pharmacology2025

Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer.

Stuthi Perimbeti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.